Phase 2 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with invasive breast cancer, confirmed by a tissue sample test.
- You had a lumpectomy (surgery to remove the tumor but keep the breast) on your left breast, and your cancer was found in certain lymph nodes but not the most distant ones (confirm with trial site for exact staging details).
- You had a mastectomy (surgery to remove the whole breast) on your left breast, had certain lymph nodes affected, and had an implant or tissue expander placed during or after surgery.
- You received chemotherapy or hormone/targeted therapy before surgery, and your post-surgery results show a certain level of cancer remaining that requires radiation to the chest wall or nearby lymph node areas.
- You do not have cancer that has spread to other parts of your body (no distant metastases).
- You are between 18 and 80 years old.
- You are generally well enough to carry out daily activities, or have only mild limitations (confirm with trial site).
- You are not currently pregnant or breastfeeding.
- You are willing and able to give written consent before starting radiation treatment.
Who may not be able to join:
- Your diagnosis is ductal carcinoma in situ (DCIS), a very early, non-invasive form of breast cancer.
- Your cancer is classified at a certain advanced stage (T4, N0, or N3c — confirm with trial site for what this means for you).
- You have previously had radiation treatment to the same side of the chest or breast.
- Your surgical margins were positive or very close, meaning cancer cells were found within 1 mm of the edge of the tissue removed during surgery.
- You have or previously had cancer in both breasts at the same time or at different times.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 021-38296666
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The rate of patients who develop radiation-associated toxicity (≥ 2 degree) in 2 years
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.